Marshall  Mohr net worth and biography

Marshall Mohr Biography and Net Worth

Marshall L. Mohr CPA serves as Independent Director of the Company. Since March 2006, he has been Executive Vice President and Chief Financial Officer of Intuitive Surgical, Inc., a provider of surgical robotics. Prior to joining Intuitive Surgical, Mr. Mohr served as Vice President and Chief Financial Officer of Adaptec, Inc. Before 2003, Mr. Mohr was an audit partner with PricewaterhouseCoopers LLP where he was most recently the managing partner of the firm’s West Region Technology Industry Group and led its Silicon Valley accounting and audit advisory practice. Since 2005, Mr. Mohr has been a member of the board of directors and Chairman of the audit committee of Plantronics, Inc., a provider of lightweight communications headsets and telephone headset systems, and also served as a member of the board of directors and Chairman of the audit committee of Atheros Communications, Inc., a developer of semiconductor system solutions for wireless communications products, from November 2003 to May 2011 when Atheros was sold to Qualcomm, Inc. Mr. Mohr holds a Bachelor of Business Administration in Accounting and Finance from Western Michigan University.

What is Marshall Mohr's net worth?

The estimated net worth of Marshall Mohr is at least $10.73 million as of February 28th, 2024. Mr. Mohr owns 26,877 shares of Intuitive Surgical stock worth more than $10,726,342 as of March 29th. This net worth evaluation does not reflect any other assets that Mr. Mohr may own. Learn More about Marshall Mohr's net worth.

How do I contact Marshall Mohr?

The corporate mailing address for Mr. Mohr and other Intuitive Surgical executives is 1020 KIFER ROAD, SUNNYVALE CA, 94086. Intuitive Surgical can also be reached via phone at (408) 523-2100 and via email at [email protected]. Learn More on Marshall Mohr's contact information.

Has Marshall Mohr been buying or selling shares of Intuitive Surgical?

In the last ninety days, Marshall Mohr has sold $41,892,853.20 in Intuitive Surgical stock. Most recently, Marshall Mohr sold 108,790 shares of the business's stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a transaction totalling $41,892,853.20. Following the completion of the sale, the vice president now directly owns 26,877 shares of the company's stock, valued at $10,349,795.16. Learn More on Marshall Mohr's trading history.

Who are Intuitive Surgical's active insiders?

Intuitive Surgical's insider roster includes Craig Barratt (Director), Myriam Curet (EVP), Myriam Curet (EVP), Robert DeSantis (EVP), Gary Guthart (CEO), Amal Johnson (Director), Amy Ladd (Director), Keith Leonard (Director), Alan Levy (Director), Marshall Mohr (CFO), Kara Reiter (SVP), David Rosa (EVP), Mark Rubash (Director), Jamie Samath (SVP), and Fredrik Widman (VP). Learn More on Intuitive Surgical's active insiders.

Are insiders buying or selling shares of Intuitive Surgical?

During the last year, insiders at the medical equipment provider sold shares 36 times. They sold a total of 438,718 shares worth more than $153,622,264.86. The most recent insider tranaction occured on March, 15th when VP Fredrik Widman sold 5,041 shares worth more than $2,001,629.87. Insiders at Intuitive Surgical own 0.9% of the company. Learn More about insider trades at Intuitive Surgical.

Information on this page was last updated on 3/15/2024.

Marshall Mohr Insider Trading History at Intuitive Surgical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/28/2024Sell108,790$385.08$41,892,853.2026,877View SEC Filing Icon  
6/14/2023Sell11,250$325.00$3,656,250.0024,136View SEC Filing Icon  
2/13/2023Sell33,249$245.61$8,166,286.8920,751View SEC Filing Icon  
10/25/2021Sell20,475$339.20$6,945,120.00View SEC Filing Icon  
7/26/2021Sell6,825$963.38$6,575,068.50View SEC Filing Icon  
4/26/2021Sell21,963$865.69$19,013,149.479,375View SEC Filing Icon  
1/29/2021Sell9,375$751.66$7,046,812.509,423View SEC Filing Icon  
10/26/2020Sell6,000$715.28$4,291,680.0020,673View SEC Filing Icon  
7/27/2020Sell7,500$677.19$5,078,925.0022,172View SEC Filing Icon  
4/29/2020Sell7,500$525.00$3,937,500.0017,672View SEC Filing Icon  
2/3/2020Sell7,500$563.21$4,224,075.0019,947View SEC Filing Icon  
10/28/2019Sell7,500$548.43$4,113,225.0020,135View SEC Filing Icon  
7/29/2019Sell15,000$526.11$7,891,650.0020,135View SEC Filing Icon  
2/5/2019Sell7,500$525.00$3,937,500.0017,059View SEC Filing Icon  
10/31/2018Sell7,500$525.00$3,937,500.0017,321View SEC Filing Icon  
7/30/2018Sell8,250$508.50$4,195,125.0018,071View SEC Filing Icon  
4/24/2018Sell7,500$448.87$3,366,525.0017,321View SEC Filing Icon  
2/5/2018Sell7,500$414.19$3,106,425.0013,816View SEC Filing Icon  
10/30/2017Sell6,000$372.22$2,233,320.0012,316View SEC Filing Icon  
4/27/2017Sell8,950$835.89$7,481,215.506,422View SEC Filing Icon  
3/15/2017Sell4,250$750.00$3,187,500.004,422View SEC Filing Icon  
2/2/2017Sell2,000$700.00$1,400,000.003,289View SEC Filing Icon  
7/27/2016Sell5,000$684.09$3,420,450.006,725View SEC Filing Icon  
5/2/2016Sell5,000$631.63$3,158,150.006,121View SEC Filing Icon  
3/3/2016Sell2,500$575.00$1,437,500.003,621View SEC Filing Icon  
2/4/2016Sell2,500$550.00$1,375,000.00535View SEC Filing Icon  
4/27/2015Sell10,000$504.08$5,040,800.00View SEC Filing Icon  
1/27/2015Sell5,000$511.14$2,555,700.00View SEC Filing Icon  
10/31/2014Sell7,500$500.00$3,750,000.00View SEC Filing Icon  
10/27/2014Sell2,500$473.50$1,183,750.00View SEC Filing Icon  
See Full Table

Marshall Mohr Buying and Selling Activity at Intuitive Surgical

This chart shows Marshall Mohr's buying and selling at Intuitive Surgical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Intuitive Surgical Company Overview

Intuitive Surgical logo
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $399.09
Low: $397.06
High: $402.50

50 Day Range

MA: $385.19
Low: $370.07
High: $400.59

2 Week Range

Now: $399.09
Low: $246.63
High: $403.76

Volume

1,124,747 shs

Average Volume

1,673,996 shs

Market Capitalization

$141.46 billion

P/E Ratio

79.34

Dividend Yield

N/A

Beta

1.36